NCT03935074

Brief Summary

Retrospective review of 5-year long term outcomes of superselective intra-arterial chemotherapy treatment in retinoblastoma in a single institute. The treatment outcomes, globe salvage rates and complications of superselective intra-arterial chemotherapy both for treating naive patients (primary treatment group) and for patients who received systemic chemotherapy previously (secondary treatment group) were evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 30, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2016

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 2, 2019

Completed
Last Updated

May 6, 2019

Status Verified

May 1, 2019

Enrollment Period

3 months

First QC Date

April 30, 2019

Last Update Submit

May 2, 2019

Conditions

Keywords

enucleationglobe salvagesuperselective intra-arterial chemotherapy

Outcome Measures

Primary Outcomes (1)

  • globe salvage

    globe salvage rate after superselective intra-arterial chemotherapy treatment for retinoblastoma

    2-5 years

Study Arms (2)

group 1

Patients who received intra-arterial chemotherapy as a first line treatment

Drug: intra-arterial administration of melphalan

group 2

Patients who received intra-arterial chemotherapy as a salvage treatment after systemic chemotherapy

Drug: intra-arterial administration of melphalan

Interventions

Eligibility Criteria

Age5 Months - 7 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with retinoblastoma and who received superselective intra-arterial chemotherapy as a first line treatment or as a salvage treatment after systemic chemotherapy

You may qualify if:

  • patients diagnosed with unilateral/bilateral retinoblastoma

You may not qualify if:

  • patients with trilateral retinoblastoma
  • extraoculer involvement
  • patients with blood dyscrasias, bleeding and clotting disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University Cerrahpasa School of Medicine Ophthalmology Department

Istanbul, 34098, Turkey (Türkiye)

Location

Related Publications (1)

  • Saglam M, Sarici A, Anagnostakou V, Yildiz B, Kocer N, Islak C, Kizilkilic O. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery. Neuroradiology. 2014 Sep;56(9):751-4. doi: 10.1007/s00234-014-1388-1. Epub 2014 Jun 10.

    PMID: 24913287BACKGROUND

MeSH Terms

Conditions

Retinoblastoma

Condition Hierarchy (Ancestors)

Neoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueRetinal NeoplasmsEye NeoplasmsNeoplasms by SiteEye Diseases, HereditaryEye DiseasesRetinal Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmology Specialist, Medical Doctor

Study Record Dates

First Submitted

April 30, 2019

First Posted

May 2, 2019

Study Start

August 30, 2016

Primary Completion

November 30, 2016

Study Completion

November 30, 2016

Last Updated

May 6, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations